Clinical trials
Withdrawn Phase 1 Lymphoma, Follicular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| City of Hope Medical Center | 1 |
| Fate Therapeutics | 1 |
| Hutchmed | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| Janssen Research & Development, LLC | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Lyndra Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 18 |
| Lymphoma, Mantle-Cell | 12 |
| Lymphoma, B-Cell, Marginal Zone | 11 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Leukemia | 4 |
| Lymphoma, Large-Cell, Immunoblastic | 4 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.